抗血小板薬の世界市場：薬剤クラス別 (アデノシン二リン酸受容体阻害剤、不可逆的阻害剤シクロオキシゲナーゼ、その他の薬剤クラス)、投与経路別 (経口および注射用)、流通チャネル別 (ドラッグストア、病院薬局、オンラインストア)、地域規模別、COVID-19の影響動向、2029年までの予測
抗血小板薬は、血小板がくっつくのを防ぎ、血栓を形成する体の能力を低下させます。これらの薬は、心臓発作、異常な心拍、脳卒中の治療に使用され、予防に役立つ可能性があります。アスピリンは、最も一般的に使用される抗血小板薬です。また、胸痛、血行不良、息切れなどの症状を和らげるのにも役立ちます。世界の抗血小板市場価値は2023年に35億3000万ドルで、2029年には45億ドルに達すると予想されます。
世界の抗血小板薬市場の成長は、医薬品開発の革新、高齢者人口の増加、心血管疾患の有病率の増加、予防医療戦略への注目の高まりなどの要因によって推進されています。CVDの既往歴のある人の増加が、抗血小板薬の持続的な需要に貢献しています。医療従事者が心血管治療における患者の転帰の改善に努める中、血栓性イベントの負担を軽減するために抗血小板薬の役割は依然として極めて重要です。さらに、新興経済国での抗血小板薬の採用の増加が、市場に有利な成長機会をさらに生み出しています。市場は、2024年から2029年の予測期間にわたって4.22%のCAGRで成長すると予想されます。
目次
Table of Contents
1. Executive Summary
2. Introduction
2.1 Antiplatelet: An Overview
2.1.1 Introduction to Antiplatelets
2.2 Antiplatelet Segmentation: An Overview
2.2.1 Antiplatelet Segmentation
3. Global Market Analysis
3.1 Global Antiplatelet Market: An Analysis
3.1.1 Global Antiplatelet Market: An Overview
3.1.2 Global Antiplatelet Market by Value
3.1.3 Global Antiplatelet Market by Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other drug classes)
3.1.4 Global Antiplatelet Market by Route of Administration (Oral and Injectable)
3.1.5 Global Antiplatelet Market by Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores)
3.1.6 Global Antiplatelet Market by Region (North America, Europe, Asia Pacific, and Rest of the World)
3.2 Global Antiplatelet Market: Drug Class Analysis
3.2.1 Global Antiplatelet Market: Drug Class Overview
3.2.2 Global Adenosine Diphosphate Receptor Inhibitors Antiplatelet Market by Value
3.2.3 Global Irreversible Inhibitors Cyclooxygenase Antiplatelet Market by Value
3.2.4 Global Other Antiplatelet Drug Classes Market by Value
3.3 Global Antiplatelet Market: Route of Administration Analysis
3.3.1 Global Antiplatelet Market: Route of Administration Overview
3.3.2 Global Oral Antiplatelet Market by Value
3.3.3 Global Injectable Antiplatelet Market by Value
3.4 Global Antiplatelet Market: Distribution Channel Analysis
3.4.1 Global Antiplatelet Market: Distribution Channel Overview
3.4.2 Global Drug Stores Antiplatelet Antiplatelet Market by Value
3.4.3 Global Hospital Pharmacies Antiplatelet Market by Value
3.4.4 Global Online Stores Antiplatelet Market by Value
4. Regional Market Analysis
4.1 North America Antiplatelet Market: An Analysis
4.1.1 North America Antiplatelet Market: An Overview
4.1.2 North America Antiplatelet Market by Value
4.1.3 North America Antiplatelet Market by Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other drug classes)
4.1.4 North America Antiplatelet Market by Route of Administration (Oral and Injectable)
4.1.5 North America Antiplatelet Market by Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores)
4.1.6 North America Antiplatelet Market by Region (The US, Canada, and Mexico)
4.1.7 The US Antiplatelet Market by Value
4.1.8 Canada Antiplatelet Market by Value
4.1.9 Mexico Antiplatelet Market by Value
4.2 Europe Antiplatelet Market: An Analysis
4.2.1 Europe Antiplatelet Market: An Overview
4.2.2 Europe Antiplatelet Market by Value
4.2.3 Europe Antiplatelet Market by Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other drug classes)
4.2.4 Europe Antiplatelet Market by Route of Administration (Oral and Injectable)
4.2.5 Europe Antiplatelet Market by Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores)
4.2.6 Europe Antiplatelet Market by Region (Germany, UK France, Italy, and rest of Europe)
4.2.7 Germany Antiplatelet Market by Value
4.2.8 UK Antiplatelet Market by Value
4.2.9 France Antiplatelet Market by Value
4.2.10 Italy Antiplatelet Market by Value
4.2.11 Rest of Europe Antiplatelet Market by Value
4.3 Asia Pacific Antiplatelet Market: An Analysis
4.3.1 Asia Pacific Antiplatelet Market: An Overview
4.3.2 Asia Pacific Antiplatelet Market by Value
4.3.3 Asia Pacific Antiplatelet Market by Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other drug classes)
4.3.4 Asia Pacific Antiplatelet Market by Route of Administration (Oral and Injectable)
4.3.5 Asia Pacific Antiplatelet Market by Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores)
4.3.6 Asia Pacific Antiplatelet Market by Region (China, Japan, India, and rest of Asia Pacific)
4.3.7 China Antiplatelet Market by Value
4.3.8 Japan Antiplatelet Market by Value
4.3.7 India Antiplatelet Market by Value
4.3.8 Rest of Asia Pacific Antiplatelet Market by Value
4.4 Rest of the World Antiplatelet Market: An Analysis
4.4.1 Rest of the World Antiplatelet Market: An Overview
4.4.2 Rest of the World Antiplatelet Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19 on Global Antiplatelet Market
5.2 Post COVID-19 Impact on Global Antiplatelet Market
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Incidence of Cardiovascular Diseases
6.1.2 Rise in Research and Development Activities
6.1.3 Rising Healthcare Expenditure
6.1.4 Rising Geriatric Population
6.1.5 Health-Conscious Consumers
6.2 Challenges
6.2.1 Availability of Alternative Therapies
6.2.2 Regulatory and Safety Considerations
6.2.3 Genetic Variability in Drug Response
6.3 Market Trends
6.3.1 Enhancements in Drug Delivery Systems
6.3.2 Combination Therapies
6.3.3 Advancements in Antiplatelet Drugs
7. Competitive Landscape
7.1 Global Antiplatelet Market: Competitive Landscape
8. Company Profiles
8.1 AstraZeneca
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 Sanofi
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Plavix Net Sales by Region
8.2.4 Business Strategy
8.3 Daiichi Sankyo Co., Ltd.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy
8.4 Bayer AG
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy
8.5 Sun Pharmaceutical Industries Ltd.
8.5.1 Business Overview
8.5.2 Reportable Segments
8.5.3 Business Strategy
8.6 Torrent Pharmaceuticals Ltd.
8.6.1 Business Overview
8.6.2 Operating Regions
8.7 Lupin Ltd.
8.7.1 Business Overview
8.7.2 Business Strategy
8.8 Cipla Limited
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy
8.9 Baxter International Inc.
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy
8.10 Takeda Pharmaceutical Company Limited
8.10.1 Business Overview
8.10.2 Revenue by Region
8.10.3 Business Strategy
8.11 Glenmark Pharmaceuticals Inc., USA
8.11.1 Glenmark Pharmaceuticals Inc., USA
8.11.2 Business Strategy
List of Figures
Figure 1: Antiplatelet Segmentation
Figure 2: Global Antiplatelet Market by Value; 2020-2023 (US$ Billion)
Figure 3: Global Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 4: Global Antiplatelet Market by Drug Class; 2023 (Percentage, %)
Figure 5: Global Antiplatelet Market by Route of Administration; 2023 (Percentage, %)
Figure 6: Global Antiplatelet Market by Distribution Channel; 2023 (Percentage, %)
Figure 7: Global Antiplatelet Market by Region; 2023 (Percentage, %)
Figure 8: Global Adenosine Diphosphate Receptor Inhibitors Antiplatelet Market by Value; 2020-2023 (US$ Billion)
Figure 9: Global Adenosine Diphosphate Receptor Inhibitors Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 10: Global Irreversible Inhibitors Cyclooxygenase Antiplatelet Market by Value; 2020-2023 (US$ Billion)
Figure 11: Global Irreversible Inhibitors Cyclooxygenase Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 12: Global Other Antiplatelet Drug Classes Market by Value; 2020-2023 (US$ Million)
Figure 13: Global Other Antiplatelet Drug Classes Market by Value; 2024-2029 (US$ Million)
Figure 14: Global Oral Antiplatelet Market by Value; 2020-2023 (US$ Billion)
Figure 15: Global Oral Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 16: Global Injectable Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 17: Global Injectable Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 18: Global Drug Stores Antiplatelet Market by Value; 2020-2023 (US$ Billion)
Figure 19: Global Drug Stores Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 20: Global Hospital Pharmacies Antiplatelet Market by Value; 2020-2023 (US$ Billion)
Figure 21: Global Hospital Pharmacies Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 22: Global Online Stores Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 23: Global Online Stores Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 24: North America Antiplatelet Market by Value; 2020-2023 (US$ Billion)
Figure 25: North America Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 26: North America Antiplatelet Market by Drug Class; 2023 & 2029 (Percentage, %)
Figure 27: North America Antiplatelet Market Drug Class by Value; 2023 & 2029 (US$ Million)
Figure 28: North America Antiplatelet Market by Route of Administration; 2023 & 2029 (Percentage, %)
Figure 29: North America Antiplatelet Market Route of Administration by Value; 2023 & 2029 (US$ Million)
Figure 30: North America Antiplatelet Market by Distribution Channel; 2023 & 2029 (Percentage, %)
Figure 31: North America Antiplatelet Market Distribution Channel by Value; 2023 & 2029 (US$ Million)
Figure 32: North America Antiplatelet Market by Region; 2023 (Percentage, %)
Figure 33: The US Antiplatelet Market by Value; 2020-2023 (US$ Billion)
Figure 34: The US Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 35: Canada Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 36: Canada Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 37: Mexico Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 38: Mexico Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 39: Europe Antiplatelet Market by Value; 2020-2023 (US$ Billion)
Figure 40: Europe Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 41: Europe Antiplatelet Market by Drug Class; 2023 & 2029 (Percentage, %)
Figure 42: Europe Antiplatelet Market Drug Class by Value; 2023 & 2029 (US$ Million)
Figure 43: Europe Antiplatelet Market by Route of Administration; 2023 & 2029 (Percentage, %)
Figure 44: Europe Antiplatelet Market Route of Administration by Value; 2023 & 2029 (US$ Million)
Figure 45: Europe Antiplatelet Market by Distribution Channel; 2023 & 2029 (Percentage, %)
Figure 46: Europe Antiplatelet Market Distribution Channel by Value; 2023 & 2029 (US$ Million)
Figure 47: Europe Antiplatelet Market by Region; 2023 (Percentage, %)
Figure 48: Germany Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 49: Germany Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 50: UK Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 51: UK Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 52: France Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 53: France Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 54: Italy Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 55: Italy Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 56: Rest of Europe Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 57: Rest of Europe Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 58: Asia Pacific Antiplatelet Market by Value; 2020-2023 (US$ Billion)
Figure 59: Asia Pacific Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 60: Asia Pacific Antiplatelet Market by Drug Class; 2023 & 2029 (Percentage, %)
Figure 61: Asia Pacific Antiplatelet Market Drug Class by Value; 2023 & 2029 (US$ Million)
Figure 62: Asia Pacific Antiplatelet Market by Route of Administration; 2023 & 2029 (Percentage, %)
Figure 63: Asia Pacific Antiplatelet Market Route of Administration by Value; 2023 & 2029 (US$ Million)
Figure 64: Asia Pacific Antiplatelet Market by Distribution Channel; 2023 & 2029 (Percentage, %)
Figure 65: Asia Pacific Antiplatelet Market Distribution Channel by Value; 2023 & 2029 (US$ Million)
Figure 66: Asia Pacific Antiplatelet Market by Region; 2023 (Percentage, %)
Figure 67: China Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 68: China Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 69: Japan Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 70: Japan Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 71: India Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 72: India Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 73: Rest of Asia Pacific Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 74: Rest of Asia Pacific Antiplatelet Market by Value; 2024-2029 (US$ Million)
Figure 75: Rest of the World Antiplatelet Market by Value; 2020-2023 (US$ Million)
Figure 76: Rest of the World Antiplatelet Market by Value; 2024-2029 (US$ Billion)
Figure 77: Global Healthcare Expenditure as a Share of GDP; 2022-2029 (Percentage, %)
Figure 78: Global Percentage Of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %)
Figure 79: AstraZeneca Revenue by Region; 2023 (Percentage, %)
Figure 80: AstraZeneca’s Brilinta Revenue by Region; 2023 (Percentage, %)
Figure 81: Sanofi Net Sales by Segments; 2023 (Percentage, %)
Figure 82: Sanofi Plavix Net Sales by Region; 2023 (Percentage, %)
Figure 83: Daiichi Sankyo Co., Ltd. Revenue by Segments; 2023 (Percentage, %)
Figure 84: Bayer AG Net Sales by Segment; 2023 (Percentage,%)
Figure 85: Sun Pharmaceutical Industries Ltd. Revenue by Segments; 2024 (Percentage,%)
Figure 86: Torrent Pharmaceuticals Ltd. Revenues by Regions; 2023 (Percentage,%)
Figure 87: Cipla Limited Revenue by Segments; 2024 (Percentage, %)
Figure 88: Baxter International Inc. Net Sales by Segments; 2023 (Percentage, %)
Figure 89: Takeda Pharmaceutical Company Limited Revenue by Region; 2023 (Percentage,%)
